Compare WBX & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WBX | MBOT |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.8M | 75.2M |
| IPO Year | 2021 | 2000 |
| Metric | WBX | MBOT |
|---|---|---|
| Price | $2.80 | $1.07 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $4.00 | ★ $5.38 |
| AVG Volume (30 Days) | 8.5K | ★ 765.1K |
| Earning Date | 11-04-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.27 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $116,887.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $142.61 | $377.83 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.30 | $0.93 |
| 52 Week High | $6.18 | $2.86 |
| Indicator | WBX | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 44.92 | 46.33 |
| Support Level | $2.64 | N/A |
| Resistance Level | $3.10 | $2.69 |
| Average True Range (ATR) | 0.12 | 0.06 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 50.57 | 63.64 |
Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments: Europe, the Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.